Table 3 Characteristics and clinical data of the enrolled patients.

From: Comprehensive biomarker profiles and chemometric filtering of urinary metabolomics for effective discrimination of prostate carcinoma from benign hyperplasia

 

PCa

BPH

t-test (p-value)

Age (mean ± std)

years

66 ± 7

65 ± 6

0.48

Body weight (mean ± std)

kg

82 ± 11

79 ± 11

0.51

Body height (mean ± std)

cm

176 ± 6

172 ± 8

0.07

BMI (mean ± std)

kg/m2

26.4 ± 3.1

27.0 ± 4.4

0.60

PSA (median–range)

ng/mL

7.4 (3.0–22.0)

2.7 (0.3–19.8)

0.01*

Prostate volume (median–range)

cm3

42 (20–98)

60 (30–200)

0.01*

Biopsy GS

Number of patients

  

3 + 4

5

/

 

4 + 3

7

/

 

4 + 4

4

/

 

4 + 5

2

/

 

5 + 4

2

/

 
  1. Symbol (*) indicates the features showing a significant p-value (lower than 0.05) for the performed Student's t-tests.
Back to article page